ProShares UltraShort NASDAQ Biotechnology
14 hedge funds and large institutions have $30.8M invested in ProShares UltraShort NASDAQ Biotechnology in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holding in Top 10
1
Calls
$55.1M
Puts
$9.6M
Top Buyers
| 1 | +$15.9M | |
| 2 | +$4.49M | |
| 3 | +$1.43M | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$1.19M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$1M |
Top Sellers
| 1 | -$8.38M | |
| 2 | -$2.31M | |
| 3 | -$912K | |
| 4 |
EM
Emancipation Management
New York
|
-$643K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$287K |